Results: SCLP

Search articles by EPIC code

Scancell – joins the Covid bandwagon. Still worthy of a tip? Er….

One of my first ever tips for ShareProphets was AIM-listed Scancell (SCLP), way back in the 2015 New Year tipfest. It has not covered me in glory, having tipped it when it was hanging around the 23-33p mark as the shares closed last night at around 5p. I had hoped that it would turn itself around and its biotech business would find a willing buyer in the end. But today the shares are up buy a thumping 46% (last seen) on news of Development of vaccine against Covid-19.  Should I be celebrating? I’m not so sure….


Scancell – FDA throws a spanner into the works//but!

AIM-listed immunotherapy cancer specialist Scancell (SCLP) announced last week that the FDA had posed a few questions regarding its application to run a Phase II combination trial for its SCIB-1 skin cancer compound alongside a checkpoint inhibitor. The market saw this as bad news, and marked the shares down heavily – but I’m not so sure it is all that serious.

Page 1 of 4 (36 articles)
Subscribe to our newsletter

Daily digest of our latest stories.

Search ShareProphets

Complete Coverage

Recent Comments